July 9, 2026 · Form 4 insider transaction
Kirn David sold 42,608 shares of 4D Molecular Therapeutics, Inc. at $12.87 per share, a transaction worth $548.2K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 5 days after the transaction.
Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on January 9, 2026.; The transaction was executed in multiple trades in prices ranging from $12.68 to $13.23, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.